Scienture Holdings (SCNX) Receivables (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Receivables came in at $385313.0 in Q2 2026, down 46.67% quarter-over-quarter from $722545.0 in Q1 2026.
Analysis
Scienture Holdings (SCNX) Receivables (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Receivables across 14 years of filings, most recently posting $385313.0 for Q2 2026.
- In Q2 2026, Receivables changed N/A year-over-year to $385313.0; the TTM figure through Jun 2026 stood at $385313.0 (changed N/A YoY), while the FY2025 annual figure was $811797.0, down 80.44% from the prior year.
- Receivables came in at $385313.0 for Q2 2026 at Scienture Holdings, down from $722545.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $18.1 million in Q1 2024 to a low of -$355921.0 in Q4 2024.
- Average Receivables over 5 years is $2.4 million, with a median of $1.0 million recorded in 2022.
- The largest YoY upside for Receivables was 1290.99% in 2024 against a maximum downside of 114.53% in 2024.
- Over 5 years, Receivables stood at $629921.0 in 2022, then surged by 288.84% to $2.4 million in 2023, then slumped by 114.53% to -$355921.0 in 2024, then jumped by 305.47% to $731328.0 in 2025, then plunged by 47.31% to $385313.0 in 2026.
- Per Business Quant data, the three most recent Receivables figures were $385313.0 in Q2 2026, $722545.0 in Q1 2026, and $731328.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 3.49 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 3.67 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 1.06 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.61 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 2.26 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 274.47 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 211.59 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 145.76 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 23.27 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 385,313.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 385,313.00 |
| Mar 31, 2026 | 722,545.00 |
| Dec 31, 2025 | 731,328.00 |
| Sep 30, 2025 | 590,050.00 |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | -355,921.00 |
| Sep 30, 2024 | 4.52 Mn |
| Jun 30, 2024 | 2.24 Mn |
| Mar 31, 2024 | 18.08 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 799,436.00 |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 629,921.00 |
| Sep 30, 2022 | 875,250.00 |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | -103,562.00 |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 1.50 Mn |